TRDA Stock-Based Compensation
Entrada Therapeutics Inc · Stock-Based Compensation
TRDA Stock-Based Compensation
Latest reported$19.37Mperiod ending
TRDA Stock-Based Comp ($294.00K → $19.37M)
Annual stock-based compensation
High-resolution chart · PNG
TRDA stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 19,609,000 | |
| 17,915,000 | |
| 13,111,000 | |
| 9,895,000 | |
| 2,526,000 | |
| 325,000 | |
| 294,000 |